UnityPoint’s Neoprobe Technology Enhances Cancer Surgery Outcomesby Lilu Anderson 26.06.2024UnityPoint Health-Grinnell introduces Neoprobe Gamma Detection for precise breast cancer surgery, enhancing patient care and personalized treatment.
RBC Maintains Outperform on Tesla Amid Q2 Delivery Estimatesby Mark Eisenberg 26.06.2024"RBC Capital maintains an 'Outperform' rating on Tesla, predicting long-term growth despite lowering Q2 2024 delivery estimates to 410,000 cars."
Bitcoin Plunge: Unprecedented Negative Sentiment Drives Declineby John Darbie 23.06.2024Bitcoin battles rare FUD wave despite $64k price. Prolonged negative sentiment grips the market, with key indices showing fear and ...
Align Technology Sees Diverse Investor Interest and Mixed Ratingsby Lilu Anderson 22.06.2024AIG sells 4,921 shares of Align Technology, reducing holdings by 19%. Major investors and analysts shift positions and ratings. Stock ...
Veris Director Invests $143K in Company Stockby Mark Eisenberg 22.06.2024Nori Gerardo Lietz buys 10,000 shares in Veris Residential, Inc., reflecting confidence in the REIT's future amidst key strategy shifts ...
Lilly’s Zepbound Resolves Sleep Apnea in 52% of Patientsby Mark Eisenberg 22.06.2024Eli Lilly's Zepbound reduces sleep apnea by up to 52% in trials, showing promise beyond weight loss. FDA approval for ...
Zealand Pharma Surges on Promising Weight Loss Drug Trial Resultsby Mark Eisenberg 21.06.2024Zealand Pharma's stock surged 17% post-positive trial results for its weight loss drug, showing promising 8.6% average weight reduction. Analysts ...
Barclays’ Caution on Tesla: Risks and Earnings Concernsby Mark Eisenberg 21.06.2024Barclays remains cautious on Tesla stock, citing weak delivery numbers, potential inventory issues, and further earnings risks with a $180 ...
EA Sports Unveils ‘Madden NFL 25’ With New BOOM Techby Lilu Anderson 21.06.2024EA Sports unveils "BOOM Tech" in Madden NFL 25, enhancing gameplay with physics-based tackling and ball carrier dynamics. Release: August ...
Morgan Stanley Upgrades ASM International Stock to Overweightby Mark Eisenberg 20.06.2024Morgan Stanley upgrades ASM International to Overweight, raises target to €800, citing strong AI-driven growth and increased order momentum.